Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
600MPE
HR+
Luminal
Oxaliplatin
DNA cross-linker
DNA cross-linker
9118.011
uM
12.80430
29.13070
-0.5219 -0.6603 1.0241 0.4039
0.9835
1.0538
600MPE
HR+
Luminal
Oxaliplatin
DNA cross-linker
DNA cross-linker
9120.021
uM
16.89330
40.58020
-0.9570 -1.0000 1.2536 0.4435
0.9886
0.6486
600MPE
HR+
Luminal
Oxamflatin
HDAC
HDAC
12224.147
uM
2.79220
7.38130
-0.9880 -1.0000 1.1301 0.3828
0.9872
0.8621
600MPE
HR+
Luminal
PD 98059
MEK
MAPK
12224.152
uM
124.1750
739.75820
0.6747 -1.0000 0.6156 0.0605
0.8626
1.0761
600MPE
HR+
Luminal
PD173074
FGFR1/3
RTK
5898.093
uM
7.82560
10.48720
-0.9800 -1.0000 3.7527 0.3030
0.9267
0.6963
600MPE
HR+
Luminal
PD184352
MEK
MAPK
12224.155
uM
inf
inf
0.6879 0.6879 0.0000 0.1877
0.1373
1.0378
600MPE
HR+
Luminal
PD184352
MEK
MAPK
12224.155
uM
inf
inf
0.6879 0.6879 0.0000 0.1877
0.1373
1.0378
600MPE
HR+
Luminal
Pemetrexed
TYMS/DHFR/GARFT
TYMS
5899.094
uM
inf
inf
1.0500 1.0500 0.0000 -0.0167
-0.1754
1.0334
600MPE
HR+
Luminal
Pemetrexed
TYMS/DHFR/GARFT
TYMS
5898.095
uM
inf
inf
0.3076 0.3076 0.0000 0.6877
0.0000
0.6975
600MPE
HR+
Luminal
PS-1145
IKK
NFKB
5898.065
uM
inf
inf
0.9898 0.9898 0.0000 0.1430
0.0000
0.6845
600MPE
HR+
Luminal
PS-1145
IKK
NFKB
5899.065
uM
inf
inf
0.8491 0.8491 0.0000 0.1182
0.0000
1.0946
600MPE
HR+
Luminal
Purvalanol A
CDK1
CDK
5898.067
uM
inf
inf
0.8837 0.8837 0.0000 0.0867
0.1356
0.6532
600MPE
HR+
Luminal
Purvalanol A
CDK1
CDK
5899.067
uM
27.81920
110.71190
-0.1721 -1.0000 0.7954 0.2510
0.9003
0.9897
600MPE
HR+
Luminal
QNZ
NFkB
NFKB
5898.096
uM
inf
0.06585
0.6881 0.6711 4.7174 0.1528
0.9145
0.6718
600MPE
HR+
Luminal
SB-3CT
MMP2/9
MMP
12224.144
uM
inf
inf
0.8442 0.8442 0.0000 0.1370
-0.1637
1.0210
600MPE
HR+
Luminal
Selumetinib
MEK
MAPK
12224.155
uM
0.53417
0.10230
0.2888 0.3014 0.5585 0.3322
0.9653
1.0378
600MPE
HR+
Luminal
Sigma A6730
AKT
AKT
12224.165
uM
6.5660
13.29760
-0.9371 -1.0000 1.5568 0.3611
0.9610
0.9714
600MPE
HR+
Luminal
Sirolimus
MTOR
MTOR
7791.068
uM
0.15062
0.04002
-0.0209 0.1737 0.3221 0.4926
0.7333
0.8032
600MPE
HR+
Luminal
Sirolimus
MTOR
MTOR
5899.068
uM
inf
0.02668
0.5818 0.6451 2.3199 0.2344
0.9310
1.0389
600MPE
HR+
Luminal
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
5899.084
uM
211.34090
1000.00000
0.1706 -0.4320 0.4006 0.1910
0.7174
1.1144
600MPE
HR+
Luminal
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
5898.085
uM
57.26150
86.20510
-0.9896 -1.0000 2.6854 0.3512
0.9042
0.7048
600MPE
HR+
Luminal
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
5898.067
uM
5.29710
7.53220
-0.9986 -1.0000 3.1208 0.5757
0.9370
0.6532
600MPE
HR+
Luminal
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
5899.067
uM
2.37830
4.93120
-0.9995 -1.0000 1.5066 0.6079
0.9889
0.9897
600MPE
HR+
Luminal
TAPI-0
TACE/Collagenase
5898.096
uM
89.24790
597.73340
0.6770 -0.9738 0.5684 0.0541
0.9121
0.6718
600MPE
HR+
Luminal
Taxol
TUBB
TUBB
9118.002
uM
0.07399
0.02651
0.3917 0.3920 1.4923 0.3215
0.9870
0.9880